Skip to main content

Day: March 11, 2024

Form 8.3 – [MATTIOLI WOODS ORD PLC] – 08 03 2024 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MATTIOLI WOODS ORD(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

BOS’ Intelligent Robotics Division Receives an Order for €615,000 

RISHON LE ZION, Israel, March 11, 2024 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) announced today that its Intelligent Robotics Division has received a €615,000 order for a robotic production line from an Israeli defense-industry customer. This order will be delivered in March 2025. Eyal Cohen, BOS’ CEO, stated: “Our strategic growth plan for the Intelligent Robotics division focuses on customers from the Israeli defense market, which have a great potential for recurring orders. It is the fourth order from the same customer since the beginning of 2023. It is a decisive vote of confidence by one of the largest defense manufacturers in Israel. We have invested extensively in our Robotics division in recent years, including in a significant restructuring...

Continue reading

Form 8.3 – [abrdn EUROPEAN LOGISTICS INCOME PLC] – 08 03 2024 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree abrdn EUROPEAN LOGISTICS INCOME PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Koil Energy Solutions Announces CEO Transition

HOUSTON, March 11, 2024 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG), an international specialist in subsea energy equipment and services, today announced the resignation of its President, CEO and CFO, Mr. Charles Njuguna due to a family health matter. Mr. Njuguna has also resigned as a member of the Company’s Board of Directors (“Board”). Mr. Njuguna will stay on through March 31, 2024 and oversee the 2023 fiscal year-end audit and financial reporting. In connection with Mr. Njuguna’s resignation, Koil Energy’s Board of Directors appointed Mr. Erik Wiik as a member of the Company’s Board effective March 8, 2024, and to serve as its next Chief Executive Officer, effective April 1, 2024. Mr. Wiik has been working with the Company as a consultant since September 2023. “Serving as CEO of Koil Energy has been the highlight...

Continue reading

Rail Vision Received Order from a Class 1 US Railroad Company for its AI-Based Safety System

Ra’anana, Israel, March 11, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced that it has received an order for its AI-driven Switch Yard System from a Class 1 freight rail company in the US. The freight rail company, which is one of the largest in North America, will install and use the system on its locomotive for evaluation and testing different scenarios related to safety. “We believe that this new order is a milestone for Rail Vision that signifies the industry’s trust in our solutions to navigate the complexities of rail operations. By leveraging AI and machine learning, we aim to transform the way railways operate, enhance safety, efficiency reliability and preserve business...

Continue reading

SeaChange to be Acquired by Partner One

BOSTON, March 11, 2024 (GLOBE NEWSWIRE) — SeaChange International, Inc. (OTC: SEAC) (“SeaChange” or the “Company”), a leading provider of video delivery, advertising, streaming platforms, and emerging Free Ad-Supported Streaming TV services (FAST) development, has entered into an asset purchase agreement (the “Purchase Agreement”) under which an affiliate of Partner One, one of the fastest-growing software conglomerates in the world, will acquire substantially all of SeaChange’s assets related to its product and services business (the “Asset Sale”), and will assume certain liabilities, for a purchase price of $30 million, less SeaChange’s cash and cash equivalents at closing (the “Closing”). SeaChange has traditionally supported clients’ Operator TV systems, Advanced Advertising insertion platforms, the StreamVid streaming enablement...

Continue reading

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks with no detectable effects on microbiota in the skin, GI tract, or vagina New Drug Application for DFD-29 currently under review by U.S. FDA SCOTTSDALE, Ariz., March 11, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, announces that data from the Phase 1 clinical trial (DFD-29-CD-006) assessing the impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on the microbial flora of healthy...

Continue reading

Interdigital to Speak at the 36th Annual Roth Conference

WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be participating in a fireside chat at the 36th Annual Roth Conference on Monday, March 18th, 2024, at 6:00 PM ET. The event will be webcast live, and an archived replay of the presentation will be available following the conference at the Investors page of the InterDigital website at www.interdigital.com. Register to attend the live webcast here. About InterDigital® InterDigital is a global research and development company focused primarily on wireless, video, artificial intelligence (“AI”), and related technologies. We design and develop foundational technologies that enable connected, immersive experiences in a broad range of communications...

Continue reading

Applied Materials Increases Cash Dividend by 25 Percent

SANTA CLARA, Calif., March 11, 2024 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that its Board of Directors has approved a 25-percent increase in the quarterly cash dividend from $0.32 to $0.40 per share. The dividend is payable on June 13, 2024 to shareholders of record as of May 23, 2024. “Our latest dividend increase reflects our confidence in Applied Materials’ ability to generate profitable growth and strong free cash flow,” said Brice Hill, Senior Vice President and CFO. “We believe Applied can continue to outperform the semiconductor equipment market in the years ahead, and we expect our services business to deliver double-digit growth and more than enough operating profit to support a growing dividend.” The quarterly cash dividend is a key component of Applied’s capital allocation strategy. Today’s announcement...

Continue reading

Reviva to Present at the UBS Virtual CNS Day

CUPERTINO, Calif., March 11, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a Fireside Chat at the UBS Virtual CNS Day, taking place virtually March 18, 2024. UBS Virtual CNS Day    Format: Fireside Chat     Date: Monday, March 18, 2024    Time: 1:30 p.m. ET    Location: Virtual To register for the event, please click here or contact your UBS representative. About Reviva Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.